Teva Pharmaceutical Industries Limited (TEVA) · 37 Years of Financial statements

Income Statement

Revenue

91

140

211

281

329

327

407

502

588

668

954

1,117

1,116

1,282

1,750

2,077

2,519

3,276

4,799

5,250

8,408

9,408

11,085

13,899

16,121

18,312

20,317

20,314

20,272

19,652

21,903

22,385

18,854

16,887

16,658

15,879

14,925

COGS

59

85

130

181

191

194

230

269

306

364

550

629

636

699

963

1,230

1,423

1,758

2,560

2,770

4,149

4,531

5,117

6,532

7,056

8,797

9,665

9,607

9,216

8,296

10,044

11,560

10,558

9,351

8,933

8,284

7,952

Gross Profit

32

55

82

100

138

133

177

234

282

304

403

488

480

583

787

847

1,095

1,519

2,239

2,481

4,259

4,877

5,968

7,367

9,065

9,515

10,652

10,707

11,056

11,356

11,859

10,825

8,296

7,536

7,725

7,595

6,973

Gross Profit Ratio

35.53%

39.18%

38.65%

35.72%

41.85%

40.66%

43.50%

46.51%

47.98%

45.47%

42.29%

43.69%

43.00%

45.48%

44.97%

40.79%

43.49%

46.36%

46.66%

47.25%

50.65%

51.84%

53.84%

53.00%

56.23%

51.96%

52.43%

52.71%

54.54%

57.79%

54.14%

48.36%

44.00%

44.63%

46.37%

47.83%

46.72%

Operating Expenses

21

35

59

56

97

81

121

146

175

188

274

314

335

384

412

471

571

634

1,065

1,168

2,163

2,482

4,699

4,301

4,766

5,505

6,473

6,746

6,566

6,242

7,207

6,834

5,427

4,816

4,668

4,495

4,283

R&D Expenses

- -

37

32

63

65

68

82

105

107

165

214

338

369

495

581

2,188

802

933

1,095

1,356

1,427

1,488

1,525

2,111

1,848

1,213

1,010

997

967

838

Selling, G&A Exp.

17

30

51

56

85

67

102

126

115

131

168

197

208

234

307

364

406

521

697

799

1,572

1,901

2,511

3,499

3,833

4,410

5,117

5,319

5,078

4,717

5,096

4,986

4,214

3,806

3,671

3,528

3,445

General and Admin. Exp.

- -

669

823

865

932

1,238

1,239

1,217

1,239

1,236

1,330

1,298

1,192

1,173

1,099

1,180

Selling and Marketing Exp.

- -

1,842

2,676

2,968

3,478

3,879

4,080

3,861

3,478

3,860

3,656

2,916

2,614

2,498

2,429

2,265

Other Expenses

4

5

8

0

13

14

19

20

24

25

44

52

59

68

- -

(100)

30

- -

96

- -

COGS and Expenses

79

120

189

237

289

275

351

414

481

553

825

943

971

1,083

1,375

1,701

1,995

2,392

3,625

3,938

6,312

7,013

9,816

10,833

11,822

14,302

16,138

16,353

15,782

14,538

17,251

18,394

15,985

14,167

13,601

12,779

12,235

Interest Income

- -

Interest Expense

- -

318

230

225

153

355

314

300

270

546

875

920

881

963

891

- -

Depreciation and Amortization

4

5

8

0

13

14

19

20

24

25

44

52

59

68

95

109

97

128

220

243

431

521

493

908

977

1,069

1,708

1,642

1,508

1,308

1,524

2,112

1,842

1,722

1,557

1,330

1,308

EBITDA

16

27

25

43

51

71

105

122

133

138

192

158

231

303

451

592

1,000

819

1,551

1,132

2,870

1,631

3,304

4,816

4,108

3,889

3,182

5,454

3,800

2,920

(15,211)

417

1,326

(1,638)

2,849

(1,683)

EBITDA ratio

17.98%

19.41%

12.74%

8.96%

13.10%

15.53%

17.51%

20.84%

20.78%

19.93%

14.47%

17.21%

14.19%

17.98%

17.31%

21.71%

23.51%

30.53%

17.07%

29.54%

13.46%

30.51%

14.71%

23.77%

29.87%

22.43%

19.14%

15.66%

26.90%

19.34%

13.33%

(67.95)%

2.21%

7.85%

(9.83)%

17.94%

(11.28)%

Operating Income

12

19

23

44

40

52

56

88

107

115

129

174

145

199

245

361

524

877

578

1,313

801

2,395

1,145

2,405

3,871

3,109

2,205

1,649

3,951

3,352

2,154

(17,484)

(1,637)

(443)

(3,572)

1,716

(2,099)

Operating Income ratio

13.05%

13.83%

10.66%

15.72%

12.25%

15.93%

13.77%

17.53%

18.16%

17.25%

13.56%

15.56%

12.99%

15.52%

13.97%

17.37%

20.81%

26.78%

12.04%

25.01%

9.53%

25.46%

10.33%

17.30%

24.01%

16.98%

10.85%

8.12%

19.49%

17.06%

9.83%

(78.11)%

(8.68)%

(2.62)%

(21.44)%

10.81%

(14.06)%

Total Other Income Exp.(Gains)

1

3

(3)

(19)

(10)

(15)

(3)

(8)

(35)

(34)

(45)

(37)

(19)

(25)

(5)

26

(4)

(95)

(42)

(318)

(202)

(225)

(153)

(386)

(399)

(313)

(1,000)

(1,330)

(895)

(959)

(822)

(834)

(1,058)

(966)

Income Before Tax

13

22

19

25

31

37

53

85

99

108

94

140

100

162

208

342

499

872

604

1,309

706

2,353

827

2,203

3,646

2,956

1,819

1,250

3,638

2,352

824

(18,379)

(2,596)

(1,265)

(4,406)

658

(3,065)

Income Before Tax ratio

14.14%

15.76%

9.05%

8.93%

9.27%

11.31%

12.93%

16.93%

16.78%

16.13%

9.89%

12.55%

8.93%

12.65%

11.89%

16.46%

19.83%

26.63%

12.58%

24.92%

8.40%

25.01%

7.46%

15.85%

22.62%

16.14%

8.95%

6.15%

17.95%

11.97%

3.76%

(82.10)%

(13.77)%

(7.49)%

(26.45)%

4.14%

(20.54)%

Income Tax Expense (Gain)

5

7

8

10

13

20

28

27

28

21

39

31

44

60

64

85

182

267

236

155

397

185

166

283

127

(137)

(43)

591

634

521

(1,933)

(195)

(278)

(168)

211

(638)

Net Income

8

15

12

17

21

24

33

58

72

80

73

102

69

118

148

278

410

691

332

1,072

546

1,952

635

2,000

3,331

2,759

1,963

1,269

3,055

1,588

329

(16,265)

(2,150)

(999)

(3,990)

417

(2,353)

Net Income Ratio

8.33%

10.60%

5.68%

6.01%

6.32%

7.25%

8.02%

11.45%

12.18%

11.95%

7.70%

9.09%

6.17%

9.19%

8.48%

13.39%

16.29%

21.09%

6.91%

20.42%

6.49%

20.75%

5.73%

14.39%

20.66%

15.07%

9.66%

6.25%

15.07%

8.08%

1.50%

(72.66)%

(11.40)%

(5.92)%

(23.95)%

2.63%

(15.77)%

EPS

0.24

0.01

0.04

0.05

0.07

0.08

0.14

0.17

0.18

0.15

0.21

0.14

0.23

0.29

0.53

0.78

1.28

0.54

1.73

0.72

2.54

0.81

2.29

3.72

3.10

2.25

1.49

3.58

1.84

0.07

(16.26)

(2.35)

(0.91)

(3.64)

0.38

(2.12)

EPS Diluted

0.22

0.01

0.04

0.05

0.06

0.08

0.14

0.17

0.18

0.15

0.21

0.14

0.23

0.28

0.51

0.76

1.20

0.50

1.59

0.69

2.38

0.78

2.23

3.67

3.09

2.25

1.49

3.56

1.82

0.07

(16.26)

(2.35)

(0.91)

(3.64)

0.38

(2.12)

Weighted Avg. Shares Outs.

437

343

338

396

365

421

426

434

437

489

479

501

516

530

529

537

613

618

756

768

780

872

896

890

872

849

853

855

955

1,016

1,021

1,091

1,095

1,102

1,110

Weighted Avg. Shares Outs. Dil.

437

343

338

396

412

421

426

434

437

489

479

501

521

546

562

590

688

681

805

830

820

896

921

893

873

850

858

864

961

1,016

1,021

1,091

1,095

1,107

1,110

SEC Link

Link

Balance Sheet

Cash and Cash Equivalents

- -

810

1,057

784

1,276

1,332

1,488

1,854

1,995

1,248

1,096

2,879

1,038

2,226

6,946

988

963

1,782

1,975

2,177

2,165

2,801

Short-Term Investments

- -

236

322

257

936

712

1,387

53

253

36

- -

Cash & Short-Term Investments

- -

1,046

1,379

1,041

2,211

2,044

2,875

1,907

2,248

1,284

1,096

2,879

1,038

2,226

6,946

988

963

1,782

1,975

2,177

2,165

2,801

Net Receivables

- -

1,075

1,332

1,874

2,180

2,922

3,546

4,653

5,019

5,476

6,213

5,572

5,338

5,408

5,350

7,523

7,128

5,822

5,676

4,581

4,529

3,696

Inventory

- -

781

1,005

1,286

1,114

1,879

2,440

3,396

3,332

3,866

5,012

5,502

5,053

4,371

3,966

4,954

4,924

4,731

4,422

4,403

3,818

3,833

Other Current Assets

- -

795

998

1,470

1,542

1,416

2,132

2,402

2,291

2,391

2,136

3,496

2,367

1,459

1,391

1,844

2,061

1,721

Total Current Assets

- -

2,901

3,716

4,202

5,505

7,640

9,859

11,426

12,141

12,042

14,453

16,355

13,720

14,396

18,398

16,961

15,382

13,794

13,464

13,005

12,573

12,051

PP&E

- -

675

827

1,278

1,361

2,193

2,515

3,699

3,766

4,357

5,947

6,315

6,635

6,535

6,544

8,073

7,673

6,868

6,950

6,854

6,477

6,158

Goodwill

- -

8,038

8,407

12,297

12,674

15,232

18,293

18,856

18,981

18,408

19,025

44,409

28,414

24,917

24,846

20,624

20,040

17,633

Intangible Assets

- -

737

927

3,309

3,111

1,987

1,919

4,581

4,053

5,751

10,316

7,745

6,476

5,512

7,675

21,487

17,640

14,005

11,232

8,923

7,466

6,270

Goodwill and Intangible Assets

- -

737

927

3,309

3,111

10,025

10,326

16,878

16,727

20,983

28,609

26,601

25,457

23,920

26,700

65,896

46,054

38,922

36,078

29,547

27,506

23,903

Investments

- -

425

534

632

991

- -

Tax Assets

- -

476

642

138

142

- -

725

574

368

386

695

596

1,453

Other Non-Current Assets

- -

314

445

844

411

613

712

- -

1,338

1,696

1,569

2,616

1,235

932

731

591

538

515

441

Total Non-Current Assets

- -

1,725

2,200

5,431

4,882

12,831

13,553

21,478

21,669

26,110

35,689

34,254

33,788

32,024

35,860

75,929

55,233

46,889

44,005

37,634

35,094

31,955

Other Assets

- -

1

- -

Total Assets

- -

4,627

5,916

9,632

10,387

20,471

23,412

32,904

33,810

38,152

50,142

50,609

47,508

46,420

54,258

92,890

70,615

60,683

57,470

50,640

47,666

44,006

Accounts Payable

- -

786

1,051

1,644

1,885

2,557

1,383

- -

2,157

2,069

1,853

1,718

1,756

1,686

1,887

Short-Term Debt

- -

739

644

560

376

742

1,841

2,906

1,301

2,771

4,280

3,006

1,804

1,761

1,585

3,276

3,646

2,216

2,345

3,188

1,426

2,109

Tax Payable

- -

Deferred Revenue

- -

Other Current Liabilities

- -

772

2,147

5,575

6,301

6,923

9,567

9,882

10,161

10,528

11,420

13,086

12,206

10,253

9,611

8,220

7,915

7,473

Total Current Liabilities

- -

1,524

1,695

2,204

2,260

4,071

5,371

8,481

7,602

9,694

13,847

12,888

11,965

12,289

13,005

18,519

17,921

14,322

13,674

13,164

11,027

11,469

Long-Term Debt

- -

1,161

815

1,513

1,773

4,585

3,347

5,537

4,311

4,110

10,236

11,712

10,387

8,566

8,383

32,524

28,829

26,700

24,997

23,210

22,033

19,452

Deferred Revenue

- -

Deferred Tax Liabilities

- -

44

35

212

219

486

459

1,723

1,741

1,348

2,610

1,849

1,247

1,101

1,748

5,215

3,277

2,140

1,096

964

784

548

Other Non-Current Liabilities

- -

63

75

303

84

152

475

803

897

998

1,106

1,293

1,273

1,109

1,195

1,639

1,843

1,727

2,640

2,241

2,578

3,846

Total Non-Current Liabilities

- -

1,268

925

2,028

2,077

5,223

4,281

8,063

6,949

6,456

13,952

14,854

12,907

10,776

11,326

39,378

33,949

30,567

28,733

26,415

25,395

23,846

Other Liabilities

- -

Capital Lease Obligations

- -

435

479

416

349

Total Liabilities

- -

2,793

2,620

4,232

4,337

9,294

9,652

16,544

14,551

16,150

27,799

27,742

24,872

23,065

24,331

57,897

51,870

44,889

42,407

39,579

36,422

35,315

Preferred Stock

- -

3,291

3,620

3,631

- -

Common Stock

- -

34

42

43

46

48

49

50

52

54

56

57

- -

Retained Earnings

- -

1,346

1,960

2,171

3,082

3,398

5,041

5,288

6,662

9,325

11,284

12,346

12,535

14,436

14,851

13,607

(3,803)

(5,958)

(6,956)

(10,946)

(10,529)

(12,882)

Other Compreh. Income(Loss)

- -

(32)

136

140

(472)

651

1,365

390

555

350

(589)

(17)

(91)

(1,343)

(1,955)

(3,159)

(1,853)

(2,459)

(2,312)

(2,399)

(2,683)

(2,838)

Other Total Stockhold. Equity

- -

482

1,159

3,035

3,390

7,047

7,272

10,574

11,956

12,223

11,450

10,389

10,071

10,170

13,530

19,215

19,330

23,068

23,184

23,314

23,433

24,411

Total Stockholders Equity

- -

1,829

3,289

5,389

6,042

11,142

13,724

16,300

19,222

21,947

22,195

22,768

22,565

23,313

29,769

33,337

17,359

14,707

13,972

10,026

10,278

8,691

Total Liab.&Stockhold. Equity

- -

4,622

5,909

9,621

10,379

20,436

23,376

32,844

33,773

38,097

49,994

50,510

47,437

46,378

54,100

91,234

69,229

59,596

56,379

49,605

46,700

44,006

Minority Interest

- -

Total Liabilities & Equity

- -

4,622

5,909

9,621

10,379

20,436

23,376

32,844

33,773

38,097

49,994

50,510

47,437

46,378

54,100

91,234

69,229

59,596

56,379

49,605

46,700

44,006

SEC Link

Link

Cash Flow Statement

Net Income

- -

24

33

58

72

80

73

102

69

118

148

278

410

691

332

1,072

546

1,952

635

2,004

3,339

2,768

1,910

1,253

3,042

1,597

311

(16,449)

(2,472)

(1,000)

(4,099)

456

(2,406)

Depreciation and Amortization

- -

14

19

20

24

25

44

52

59

68

95

109

97

128

220

243

431

521

493

908

977

1,069

1,708

1,642

1,508

1,308

1,524

2,112

1,842

1,722

1,557

1,330

1,308

Deferred Income Tax

- -

2

4

(2)

(1)

0

(9)

21

3

(3)

(1)

(32)

(29)

27

(7)

(89)

111

27

(140)

(199)

(500)

(690)

(1,380)

(226)

237

15

(2,331)

(837)

(985)

(696)

(120)

- -

Stock Based Compensation

- -

63

54

80

91

82

64

95

117

124

133

155

119

129

119

124

Change in Working Capital

- -

(32)

(26)

(35)

(59)

(3)

(124)

23

(61)

(53)

(114)

(137)

(141)

(90)

30

89

(218)

(854)

76

445

(253)

597

414

968

290

967

1,219

(363)

(1,823)

(896)

(2,188)

(1,701)

2,564

Accounts Receivable

- -

(775)

(181)

(362)

- -

936

85

710

763

343

514

88

(394)

(293)

(574)

1,140

Inventory

- -

(16)

(19)

(39)

(9)

(78)

17

(5)

17

(56)

(73)

(149)

(156)

(85)

103

(112)

(421)

(548)

163

(16)

(410)

(449)

399

230

129

753

266

26

271

41

380

- -

Accounts Payable

- -

1,399

463

(295)

543

(19)

378

(614)

(12)

640

(1,801)

(500)

643

(463)

764

- -

Other Working Capital

- -

Other Non-Cash Items

- -

1

(1)

(2)

3

9

(3)

1

17

40

24

19

(74)

640

(27)

1,388

83

1,937

102

192

109

1,148

690

418

1,316

2,032

20,405

5,581

1,788

6,513

714

- -

Cash Provided by Operating Activities

- -

9

28

38

105

(7)

194

70

154

166

273

354

627

1,249

1,370

2,058

1,813

3,231

3,373

4,136

4,134

4,572

3,237

5,127

5,542

5,225

3,507

2,446

748

1,216

798

1,590

CAPEX

- -

(22)

(27)

(45)

(80)

(113)

(135)

(63)

(136)

(67)

(89)

(134)

(160)

(208)

(311)

(310)

(390)

(542)

(681)

(719)

(710)

(1,053)

(1,104)

(1,031)

(929)

(772)

(901)

(874)

(651)

(525)

(578)

(562)

(548)

Acquisitions Net

- -

(221)

(31)

- -

(156)

(8)

(1,989)

(34)

(3,587)

(18)

(4,749)

- -

(4,951)

(6,561)

- -

(39)

(363)

(3,309)

(36,148)

43

- -

68

Purchases of Investments

- -

(6)

- -

(12)

- -

(2)

(0)

(2)

(8)

(1)

(6)

(62)

(351)

(473)

(536)

(614)

(563)

(5,298)

(2,155)

(433)

(436)

(217)

(201)

(160)

(324)

(2,003)

(481)

(200)

(119)

(8)

(55)

(47)

(1)

Sales/Maturities of Investments

- -

5

1

5

- -

2

0

5

8

13

- -

4

270

436

422

519

4,520

3,381

236

613

- -

172

4

Other Investing Activities

- -

(20)

(24)

1

(1)

(4)

7

(0)

7

11

28

5

(1)

(17)

4

(1)

(37)

(15)

67

- -

29

230

171

83

166

519

1,790

3,195

2,636

1,888

1,496

1,960

1,133

Cash Used for Investing Activities

- -

(48)

(47)

(56)

(76)

(119)

(127)

(65)

(131)

(270)

(84)

(191)

(665)

(435)

(2,396)

(538)

(4,058)

(1,353)

(4,137)

(916)

(5,455)

(7,601)

(1,134)

(1,147)

(1,450)

(5,565)

(35,740)

2,164

1,866

1,355

863

1,523

656

Debt Repayment

- -

(141)

(2,327)

(2,891)

(1,565)

(2,213)

(3,133)

(839)

(2,521)

(999)

(3,300)

(7,446)

(3,944)

(2,430)

(7,840)

- -

Common Stock Issued

- -

10

2

- -

0

1

3

2

8

13

5

9

35

79

134

180

212

- -

3,291

329

- -

Common Stock Repurchased

- -

(1)

(2)

(4)

(5)

- -

(4)

- -

(6)

- -

(189)

(380)

(234)

(152)

- -

(99)

(899)

(1,161)

(497)

(500)

(439)

- -

Dividends Paid

- -

(4)

(5)

(8)

(16)

(15)

(22)

(20)

(18)

(28)

(33)

(47)

(76)

(121)

(162)

(229)

(299)

(388)

(528)

(668)

(800)

(855)

(1,089)

(1,156)

(1,155)

(1,558)

(1,161)

(22)

(52)

- -

Other Financing Activities

- -

30

28

53

58

52

147

(116)

77

161

280

294

382

71

1,083

95

2,307

(123)

1,887

590

4,231

6,600

2,551

836

120

5,629

27,445

(1,289)

4,117

2,070

545

5,668

(1,487)

Cash Used/Provided by Financing Activities

- -

35

25

45

40

34

131

(135)

55

151

266

267

338

30

852

(313)

2,024

(362)

1,358

(2,265)

573

3,336

(1,678)

(3,883)

(2,375)

4,805

25,217

(5,750)

(3,351)

(1,926)

(1,885)

(2,172)

(1,487)

Effect of Forex Changes on Cash

- -

0

(1)

(4)

1

(5)

(4)

(1)

15

26

22

(28)

32

58

(86)

(51)

(1)

(21)

23

(48)

(114)

(62)

(660)

54

(142)

16

8

(128)

- -

Net Change In Cash

- -

35

25

45

3

21

(4)

(10)

(4)

30

343

348

41

247

(273)

492

56

156

366

141

(747)

(152)

1,783

(1,841)

1,188

4,720

(5,958)

(25)

819

193

202

21

636

Cash at the End of Period

- -

42

63

61

51

47

77

421

769

810

1,057

784

1,276

1,332

1,488

1,854

1,995

1,248

1,096

2,879

1,038

2,226

6,946

988

963

1,782

1,975

2,177

2,198

2,834

Cash at the Beginning of Period

- -

12

8

14

40

42

65

61

51

47

77

421

769

810

1,057

784

1,276

1,332

1,488

1,854

1,995

1,248

1,096

2,879

1,038

2,226

6,946

988

963

1,782

1,975

2,177

2,198

Free Cash Flow

- -

(13)

1

(8)

(41)

(7)

(142)

130

(65)

87

76

139

193

419

938

1,060

1,668

1,271

2,550

2,654

3,426

3,081

3,468

2,206

4,198

4,770

4,324

2,633

1,795

223

638

236

1,042

SEC Link

Link

Forex Rate

- -

Powered by AI

Teva Pharmaceutical Industries Limited

7.45